Patent 7645881 was granted and assigned to Ptc Therapeutics, Inc. on January, 2010 by the United States Patent and Trademark Office.
In accordance with the present invention, compounds that can inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided.